Homology-directed dna repair, mitomycin-c resistance, and chromosome stability is restored with correction of a Brca1 mutation
- PMID: 11406561
Homology-directed dna repair, mitomycin-c resistance, and chromosome stability is restored with correction of a Brca1 mutation
Abstract
Chromosomal breaks occur spontaneously as a result of normal DNA metabolism and after exposure to DNA-damaging agents. A major pathway involved in chromosomal double-strand break repair is homologous recombination. In this pathway, a DNA sequence with similarity to a damaged chromosome directs the repair of the damage. The protein products of the hereditary breast cancer susceptibility genes, BRCA1 and BRCA2, interact with the Rad51 protein, a central component of homologous repair pathways. We have recently shown that this interaction is significant by demonstrating that Brca1- and BRCA2-deficient cells are defective in homology-directed chromosomal break repair. We confirm that Brca1-deficient embryonic stem (ES) cells are defective in gene _targeting and homology-directed repair of an I-Sce I-induced chromosome break. The phenotypic paradigm that defines homology-directed repair mutants is extended to these Brca1-deficient cells by the demonstration of 100-fold sensitivity to the interstrand cross-linking agent mitomycin-C and spontaneous chromosome instability. Interestingly, although chromosome aberrations were evident, aneuploidy was not observed. Repair phenotypes are partially restored by expression of a Brca1 transgene, whereas correction of one mutated Brca1 allele through gene _targeting fully restores mitomycin-C resistance and chromosome stability. We conclude that the inability to properly repair strand breaks by homology-directed repair gives rise to defects in chromosome maintenance that promote genetic instability and, it is likely, tumorigenesis.
Similar articles
-
Hypersensitivity of Brca1-deficient MEF to the DNA interstrand crosslinking agent mitomycin C is associated with defect in homologous recombination repair and aberrant S-phase arrest.Oncogene. 2005 Jun 9;24(25):4009-16. doi: 10.1038/sj.onc.1208575. Oncogene. 2005. PMID: 15782115
-
Deletion of Brca2 exon 27 causes hypersensitivity to DNA crosslinks, chromosomal instability, and reduced life span in mice.Genes Chromosomes Cancer. 2003 Apr;36(4):317-31. doi: 10.1002/gcc.10148. Genes Chromosomes Cancer. 2003. PMID: 12619154
-
Defective DNA strand break repair after DNA damage in prostate cancer cells: implications for genetic instability and prostate cancer progression.Cancer Res. 2004 Dec 1;64(23):8526-33. doi: 10.1158/0008-5472.CAN-04-1601. Cancer Res. 2004. PMID: 15574758
-
Emerging roles of BRCA1 in transcriptional regulation and DNA repair.J Cell Physiol. 1999 Dec;181(3):385-92. doi: 10.1002/(SICI)1097-4652(199912)181:3<385::AID-JCP2>3.0.CO;2-4. J Cell Physiol. 1999. PMID: 10528224 Review.
-
Analysis of DNA double-strand break repair pathways in mice.Mutat Res. 2007 Jan 3;614(1-2):95-108. doi: 10.1016/j.mrfmmm.2006.01.022. Epub 2006 Jun 23. Mutat Res. 2007. PMID: 16797606 Review.
Cited by
-
Combination of PARP Inhibitors and Androgen Receptor Pathway Inhibitors in Metastatic Castration-Resistant Prostate Cancer.Drugs. 2024 Sep;84(9):1093-1109. doi: 10.1007/s40265-024-02071-y. Epub 2024 Jul 26. Drugs. 2024. PMID: 39060912 Free PMC article. Review.
-
TRAIL Receptor _targeting Agents Potentiate PARP Inhibitor Efficacy in Pancreatic Cancer Independently of BRCA2 Mutation Status.Cancers (Basel). 2022 Oct 26;14(21):5240. doi: 10.3390/cancers14215240. Cancers (Basel). 2022. PMID: 36358659 Free PMC article.
-
FANCJ/BRIP1 recruitment and regulation of FANCD2 in DNA damage responses.Chromosoma. 2010 Dec;119(6):637-49. doi: 10.1007/s00412-010-0285-6. Epub 2010 Jul 31. Chromosoma. 2010. PMID: 20676667 Free PMC article.
-
BRCA1 Mutation-Specific Responses to 53BP1 Loss-Induced Homologous Recombination and PARP Inhibitor Resistance.Cell Rep. 2018 Sep 25;24(13):3513-3527.e7. doi: 10.1016/j.celrep.2018.08.086. Cell Rep. 2018. PMID: 30257212 Free PMC article.
-
Homology-Directed Repair and the Role of BRCA1, BRCA2, and Related Proteins in Genome Integrity and Cancer.Annu Rev Cancer Biol. 2018 Mar;2:313-336. doi: 10.1146/annurev-cancerbio-030617-050502. Epub 2017 Dec 1. Annu Rev Cancer Biol. 2018. PMID: 30345412 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous